- Home
- ATSG vs KNSA Comparison
ATSG vs KNSA Comparison
Compare ATSG & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATSG
- KNSA
- Stock Information
- Founded
- ATSG 1980
- KNSA 2015
- Country
- ATSG United States
- KNSA United Kingdom
- Employees
- ATSG N/A
- KNSA N/A
- Industry
- ATSG Air Freight/Delivery Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- ATSG Consumer Discretionary
- KNSA Health Care
- Exchange
- ATSG Nasdaq
- KNSA Nasdaq
- Market Cap
- ATSG 1.5B
- KNSA 1.4B
- IPO Year
- ATSG N/A
- KNSA 2018
- Fundamental
- Price
- ATSG $22.30
- KNSA $20.02
- Analyst Decision
- ATSG Buy
- KNSA Strong Buy
- Analyst Count
- ATSG 5
- KNSA 5
- Target Price
- ATSG $20.60
- KNSA $36.60
- AVG Volume (30 Days)
- ATSG 1.1M
- KNSA 567.6K
- Earning Date
- ATSG 03-04-2025
- KNSA 02-25-2025
- Dividend Yield
- ATSG N/A
- KNSA N/A
- EPS Growth
- ATSG N/A
- KNSA N/A
- EPS
- ATSG N/A
- KNSA N/A
- Revenue
- ATSG $1,962,220,000.00
- KNSA $384,098,000.00
- Revenue This Year
- ATSG N/A
- KNSA $60.10
- Revenue Next Year
- ATSG $4.58
- KNSA $34.22
- P/E Ratio
- ATSG N/A
- KNSA N/A
- Revenue Growth
- ATSG N/A
- KNSA 54.41
- 52 Week Low
- ATSG $11.62
- KNSA $16.56
- 52 Week High
- ATSG $22.35
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- ATSG 64.79
- KNSA 53.15
- Support Level
- ATSG $22.24
- KNSA $19.31
- Resistance Level
- ATSG $22.34
- KNSA $20.20
- Average True Range (ATR)
- ATSG 0.06
- KNSA 0.80
- MACD
- ATSG -0.01
- KNSA 0.06
- Stochastic Oscillator
- ATSG 78.26
- KNSA 72.80
About ATSG Air Transport Services Group Inc
Air Transport Services Group Inc along with its subsidiaries operates within the airfreight and logistics industry. It leases aircraft and provides airline operations, ground services, aircraft modification and maintenance, and other support services mainly to the cargo transportation and package delivery industries. The company has two reportable segments namely Cargo Aircraft Management and ACMI Services (Aircraft, Crew, Maintenance, and Insurance). It generates a majority of its revenue from the ACMI services segment.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.